CompletedNot Applicable

Immune Registry for Organ Transplantation From COVID Positive Donors.

United States20 participantsStarted 2022-12-29

Plain-language summary

The purpose of this study is to collect data generated by standard clinical practice to determine the short term and long term clinical outcomes of recipients of solid organ transplantation from COVID-19 infected donors and compare it to recipients with organ transplant from COVID-19 negative donors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Adult (\>18 years old) male and female solid organ transplant recipients Exclusion Criteria: * Absence of informed consent for the clinical protocol and the registry. * Prisoners will be excluded from the study.

What they're measuring

Number of participants who test positive for COVID-19

Timeframe: 1 week post transplant

Serum COVID-19 T-cell specific immune response

Timeframe: 4 week post transplant

Trial details

NCT IDNCT05595837

SponsorVirginia Commonwealth University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-20

View on ClinicalTrials.gov More COVID-19 trials